The global Bovine Lactoferrin Market is predicted to expand at a CAGR of 15.8% between 2023 and 2033, from US$ 772.39 Million to US$ 3,349.05 Million. The increasing consumer awareness of health and diet and the growing incidences of skin-related medical issues are expected to stimulate demand. Lactoferrin is thought to have antiviral, antimicrobial, antiparasitic, …
Category Archives: Healthcare Trends
Global Nano Dentistry Market to reach US$ 1.98 Billion in 2033; Nano Ceramics to be Primarily Used Material: FMI Study
The global Nano Dentistry Market is valued at US$ 838.54 Million in 2022 and is expected to achieve a market valuation of US$ 906.66 Million in 2023. It is further estimated to reach a market valuation of US$ 1.98 Billion by the end of the forecast period while exhibiting a CAGR of 8.12%. The growing …
DNA Diagnostics Market | Sysmex, Bayer Diagnostic, Roche Diagnostics, Abbott Laboratories | By 2032
The DNA Diagnostics Market generated US$ 20.9 billion in 2021 and is anticipated to grow by 9.6% year over year to reach US$ 22.9 billion in 2022. The industry is anticipated to increase to US$ 51.5 billion by 2032 as a result of the growing support from various governmental bodies. During the forecast period of …
Robotic Wheelchair Market | Sunrise Medical LLC, WHILL Inc, Permobil, MEYRA GmbH | By 2032
As per Future Market Insights’ latest revised industry analysis, the global Robotic Wheelchair Market is valued at over US$ 114.0 Mn in 2021 and is expected to exhibit an estimated value of US$ 377.4 Mn by the end of 2032. Mobility issues have been an important concern in the elderly population and integrated robotics has enforced the rise in …
Dental Burs Market | MANI INC., SHOFU Inc., Bresseler USA, Golden Star Medical Co Ltd | By 2032
With an anticipated market value of over US$ 139.2 Million as of 2022, the Dental Burs Market size is expected to experience a significant CAGR growth value of about 7.8% from 2022 to 2032, reaching an estimated market value of US$ 295.6 Million in 2032. Specialty clinics will account for a significant 40.1% of the end-user sector of the global …
Dental Autoclaves Market is projected to reach US$ 487.6 Mn by 2032 at a 5.3% CAGR
By the end of 2032, the Dental Autoclaves Market is anticipated to reach US$ 487.6 Mn, with sales rising at a 5.3% CAGR. The global dental autoclaves market was valued at US$ 277.4 Mn in 2021 and is expected to exhibit a CAGR of close to 5.3% over the forecast period. Equipment sterilization and management is an important aspect of any clinical …
Alzheimer’s Therapeutics Market | AbbVie Inc. Teva Pharmaceuticals Ltd., Eisai Co. Ltd., Janssen Pharmaceuticals Inc. | By 2032
The global Alzheimer’s Therapeutics Market growth is anticipated to reach US$ 2.8 billion in 2022 and grow at a CAGR of 9.3% to US$ 6.8 billion by 2032. In 2021, Donepezil will hold the top spot in the global medication market with a share of 68.4%, according to a recent analysis by Future Market Insights. Alzheimer’s Therapeutics …
Bacteriophage Market | Life extension, Arthur Andrew Medical, Deerland Probiotics & Enzymes Inc., BioChimpharm | By 2031
The global demand for Bacteriophage Market is expected to grow at a 4.2% CAGR from 2021 to 2031, reaching a valuation of US$ 41.46 Mn in 2021. According to the study, the oral route of administration segment held a significant share of around 97% of the global market in 2021. Rising demand of phage probiotics due …
Healthcare API Market | MuleSoft Inc., Practo Technologies Pvt. Ltd., General Electric Company, Athenahealth | By 2032
The Healthcare API Market is projected to grow at a CAGR of 3.6% during the forecast period, from US$ 215.6 Mn in 2022 to US$ 306.6 Mn in 2032. The global healthcare API market is expected to grow due to the increasing acceptance of Application Programming Interfaces (API) and integrated Electronic Health Records (EHRs) that give simplicity and …
Viral Vector Development Market is projected to reach US$3.2 billion by 2032 at a CAGR of 18.2%
The global Viral Vector Development Market, which was forecast to be worth US$ 534 million in 2021, is expected to increase to US$3.2 billion by 2032, at a CAGR of 18.2% through 2032. The increased prevalence of target diseases and disorders, the accessibility of funding for therapeutic gene strategies, the efficacy of viral vectors in gene …